Paul Hartmann (PHH2.F) Stock Price
Paul Hartmann Price
Revenue has compounded at 3.6% per year over the past 19 years to 2.45 B EUR. Earnings per share have grown at 2.3% per year over the last 19 years. Paul Hartmann's net margin stands at 2.5%, down from 4.1% several years earlier. Paul Hartmann currently offers a dividend yield of about 4.27%. The payout ratio is around 46% of earnings. The dividend has grown at 4.8% per year over the past 19 years.
Paul Hartmann stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Paul Hartmann business model & stock analysis
Frequently asked questions about Paul Hartmann
The business model of Paul Hartmann AG revolves around providing healthcare solutions and products. As a leading international supplier, Paul Hartmann AG specializes in medical and hygiene products, including wound care, incontinence management, surgical supplies, and hospital hygiene. The company focuses on improving patients' quality of life, supporting healthcare professionals, and delivering innovative solutions for various medical settings. With a strong commitment to sustainability and innovation, Paul Hartmann AG aims to contribute to the advancement of healthcare worldwide.
Paul Hartmann AG is primarily active in the healthcare and medical supplies industry.
The main competitors of Paul Hartmann AG in the market include companies such as Johnson & Johnson, B. Braun Melsungen AG, and Smith & Nephew PLC.
Paul Hartmann AG is a renowned company in the healthcare industry. Established in 1818, Paul Hartmann AG has a rich history spanning over two centuries. The company specializes in developing and manufacturing medical and hygiene products for professional and personal use. Over the years, Paul Hartmann AG has gained a strong reputation for its high-quality products and innovative solutions that enhance patient care. With a global presence, the company focuses on providing healthcare professionals and patients with reliable and effective products. Paul Hartmann AG continues to evolve and adapt to changing healthcare needs, staying true to its commitment to improving lives through its diverse product range.
Paul Hartmann AG, a leading global provider of medical and hygiene products, has achieved several significant milestones throughout its history. Established in 1818, the company has built a strong reputation for delivering innovative solutions in the healthcare industry. Over the years, Paul Hartmann AG has successfully expanded its global presence, becoming a trusted partner for medical professionals and institutions worldwide. The company's commitment to quality and continuous improvement has enabled it to develop advanced technologies and products that promote better patient care and infection prevention. With a rich heritage of over 200 years, Paul Hartmann AG continues to drive sustainable growth and make noteworthy contributions to the healthcare sector.
Paul Hartmann AG is primarily present across multiple countries and regions. These include Germany, France, the United Kingdom, Italy, Spain, Poland, Russia, and several other European countries. Additionally, the company has a strong presence in North America, South America, and Asia. With its global reach, Paul Hartmann AG serves as a leading provider of medical and hygiene products, catering to various healthcare facilities and consumers worldwide.
Paul Hartmann AG represents a strong commitment to delivering quality healthcare products and services. Their corporate philosophy revolves around innovative solutions, customer-centric approach, and sustainability. With a focus on patient care and safety, Paul Hartmann AG aims to provide reliable and effective healthcare solutions globally. The company believes in fostering long-term partnerships with healthcare professionals and organizations to improve the overall well-being of patients. By continuously evolving and adapting to the changing industry landscape, Paul Hartmann AG strives to create value for its customers, shareholders, and society as a whole.
The Paul Hartmann share (PHH2.F) is listed on 5 stock exchanges, including: XETRA (PHH2.DE), Frankfurt (PHH2.F), München (PHH2.MU), Stuttgart (PHH2.SG), Berlin (PHH2.BE).
The Paul Hartmann AG is a German company that specializes in the production of medical articles and products such as wound dressings and medical disposables. The company focuses on four different business areas: wound management, incontinence management, surgical cover and protection, and disinfection and hygiene. In the wound management sector, the company offers a wide range of state-of-the-art dressings and wound care products. These products range from simple band-aids to highly absorbent and rapidly diffusing wound dressings. The high-quality materials and unique technologies used in manufacturing ensure optimal wound care and accelerate the healing process. In the incontinence management sector, Hartmann provides disposable products for incontinence care. Here too, the company covers the entire spectrum from mild to severe cases. The products include specialized diapers, bed and underpads, as well as pads for men and women. Special emphasis is placed on skin care to avoid skin irritations and infections. In the surgical cover and protection category, Hartmann offers articles for the operating room, such as surgical gloves, masks, and clothing. The company places special emphasis on quality and safety. The products are tailored to the needs of all parties involved to ensure protection and comfort for everyone. Finally, the company also offers products for disinfection and hygiene. These include disinfectants, cleaning agents, and soaps for hospital use and general application. The products undergo strict regulations and are subject to approval by the relevant regulatory authorities. The business model of Paul Hartmann AG is based on providing high-quality and innovative medical products. The company places the highest value on quality and safety to provide optimal support to patients and medical professionals. Close cooperation with doctors and caregivers, as well as compliance with all legal regulations, ensures smooth operations in clinics, care facilities, and pharmacies. The company operates global distribution networks and works closely with all key market participants. Special focus is placed on research and development to continuously improve the products and meet the needs of customers. The company invests in modern technologies and efficient production processes to optimize costs while ensuring high-quality product standards. Overall, the business model of Paul Hartmann AG is a prime example of a successful company in the medical field. The commitment to quality, innovation, and customer service has made the company a significant player in the industry.
The revenue cannot currently be calculated for Paul Hartmann.
The profit cannot currently be calculated for Paul Hartmann.
The P/E ratio cannot be calculated for Paul Hartmann at the moment.
The P/S cannot be calculated for Paul Hartmann currently.
The Eulerpool Quality Score for Paul Hartmann is 3/10.
The ISIN of Paul Hartmann is DE0007474041. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Paul Hartmann is 747404. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Paul Hartmann is PHH2.F. The ticker symbol is used to trade Paul Hartmann shares on the stock exchange.
Paul Hartmann stock
Paul Hartmann Peer Group
Paul Hartmann Ticker
Paul Hartmann FIGI
All fundamentals and in-depth analysis of Paul Hartmann
Our stock analysis for Paul Hartmann stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Paul Hartmann. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.